Disclaimer:
Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.
Marinol
Overview
What is Marinol?
Dronabinol is a cannabinoid designated chemically as (6aR,10aR)-6a,7,8,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]-pyran-1-ol. Dronabinol has the following empirical and structural formulas:
CHO (molecular weight = 314.46)
Dronabinol, the active ingredient in MARINOL (dronabinol capsules, USP), is synthetic delta-9-tetrahydrocannabinol (delta-9-THC).
Dronabinol is a light yellow resinous oil that is sticky at room temperature and hardens upon refrigeration. Dronabinol is insoluble in water and is formulated in sesame oil. It has a pKa of 10.6 and an octanol-water partition coefficient: 6,000:1 at pH 7.
Each MARINOL capsule strength is formulated with the following inactive ingredients: 2.5 mg capsule contains gelatin, glycerin, sesame oil, and titanium dioxide; 5 mg capsule contains iron oxide red and iron oxide black, gelatin, glycerin, sesame oil, and titanium dioxide; 10 mg capsule contains iron oxide red and iron oxide yellow, gelatin, glycerin, sesame oil, and titanium dioxide.
What does Marinol look like?





What are the available doses of Marinol?
MARINOL is supplied as round, soft gelatin capsules for oral use as follows:
What should I talk to my health care provider before I take Marinol?
How should I use Marinol?
MARINOL is indicated in adults for the treatment of:
Starting Dosage
The recommended adult starting dosage of MARINOL is 2.5 mg orally twice daily, one hour before lunch and dinner.
In elderly patients or patients unable to tolerate 2.5 mg twice daily, consider initiating MARINOL at 2.5 mg once daily one hour before dinner or at bedtime to reduce the risk of central nervous system (CNS) symptoms .
Dosing later in the day may reduce the frequency of CNS adverse reactions. CNS adverse reactions are dose-related ; therefore monitor patients and reduce the dosage as needed. If CNS adverse reactions of feeling high, dizziness, confusion, and somnolence occur, they usually resolve in 1 to 3 days and usually do not require dosage reduction. If CNS adverse reactions are severe or persistent, reduce the dosage to 2.5 mg in the evening or at bedtime.
Dosage Titration
If tolerated and further therapeutic effect is desired, the dosage may be increased gradually to 2.5 mg one hour before lunch and 5 mg one hour before dinner. Increase the dose of MARINOL gradually in order to reduce the frequency of dose-related adverse reactions .
Most patients respond to 2.5 mg twice daily, but the dose may be further increased to 5 mg one hour before lunch and 5 mg one hour before dinner, as tolerated to achieve a therapeutic effect.
Maximum Dosage: 10 mg twice daily.
What interacts with Marinol?
Sorry No Records found
What are the warnings of Marinol?
Sorry No Records found
What are the precautions of Marinol?
Sorry No Records found
What are the side effects of Marinol?
Sorry No records found
What should I look out for while using Marinol?
MARINOL is contraindicated in patients with a history of a hypersensitivity reaction to dronabinol or sesame oil. Reported hypersensitivity reactions to dronabinol capsules include lip swelling, hives, disseminated rash, oral lesions, skin burning, flushing and throat tightness .
What might happen if I take too much Marinol?
Signs and symptoms of dronabinol overdosage include drowsiness, euphoria, heightened sensory awareness, altered time perception, reddened conjunctiva, dry mouth, tachycardia, memory impairment, depersonalization, mood alteration, urinary retention, reduced bowel motility, decreased motor coordination, lethargy, slurred speech, and postural hypotension. Patients may also experience panic reactions if they have a prior history of nervousness or anxiety, and seizures may occur in patients with existing seizure disorders.
It is not known if dronabinol can be removed by dialysis in cases of overdose.
If over-exposure of MARINOL occurs, call your Poison Control Center at 1-800-222-1222 for current information on the management of poisoning or overdosage.
How should I store and handle Marinol?
Store at 25°C (77°F); excursions permitted to 15 to 30°C (59 to 86°F) [see USP Controlled Room Temperature]. Pharmacist: Dispense in a tight, light-resistant container with a child-resistant closure and medication guide. Store at 25°C (77°F); excursions permitted to 15 to 30°C (59 to 86°F) [see USP Controlled Room Temperature]. Pharmacist: Dispense in a tight, light-resistant container with a child-resistant closure and medication guide. MARINOL (dronabinol capsules, USP)2.5 mg white capsules (Identified UM).NDC 0051-0021-21 (Bottle of 60 capsules).5 mg dark brown capsules (Identified UM).NDC 0051-0022-21 (Bottle of 60 capsules).10 mg orange capsules (Identified UM).NDC 0051-0023-21 (Bottle of 60 capsules).Storage ConditionsMARINOL capsules should be packaged in a well-closed container and stored in a cool environment between 8° and 15°C (46° and 59°F) and alternatively could be stored in a refrigerator. Protect from freezing.MARINOL (dronabinol capsules, USP)2.5 mg white capsules (Identified UM).NDC 0051-0021-21 (Bottle of 60 capsules).5 mg dark brown capsules (Identified UM).NDC 0051-0022-21 (Bottle of 60 capsules).10 mg orange capsules (Identified UM).NDC 0051-0023-21 (Bottle of 60 capsules).Storage ConditionsMARINOL capsules should be packaged in a well-closed container and stored in a cool environment between 8° and 15°C (46° and 59°F) and alternatively could be stored in a refrigerator. Protect from freezing.MARINOL (dronabinol capsules, USP)2.5 mg white capsules (Identified UM).NDC 0051-0021-21 (Bottle of 60 capsules).5 mg dark brown capsules (Identified UM).NDC 0051-0022-21 (Bottle of 60 capsules).10 mg orange capsules (Identified UM).NDC 0051-0023-21 (Bottle of 60 capsules).Storage ConditionsMARINOL capsules should be packaged in a well-closed container and stored in a cool environment between 8° and 15°C (46° and 59°F) and alternatively could be stored in a refrigerator. Protect from freezing.MARINOL (dronabinol capsules, USP)2.5 mg white capsules (Identified UM).NDC 0051-0021-21 (Bottle of 60 capsules).5 mg dark brown capsules (Identified UM).NDC 0051-0022-21 (Bottle of 60 capsules).10 mg orange capsules (Identified UM).NDC 0051-0023-21 (Bottle of 60 capsules).Storage ConditionsMARINOL capsules should be packaged in a well-closed container and stored in a cool environment between 8° and 15°C (46° and 59°F) and alternatively could be stored in a refrigerator. Protect from freezing.MARINOL (dronabinol capsules, USP)2.5 mg white capsules (Identified UM).NDC 0051-0021-21 (Bottle of 60 capsules).5 mg dark brown capsules (Identified UM).NDC 0051-0022-21 (Bottle of 60 capsules).10 mg orange capsules (Identified UM).NDC 0051-0023-21 (Bottle of 60 capsules).Storage ConditionsMARINOL capsules should be packaged in a well-closed container and stored in a cool environment between 8° and 15°C (46° and 59°F) and alternatively could be stored in a refrigerator. Protect from freezing.MARINOL (dronabinol capsules, USP)2.5 mg white capsules (Identified UM).NDC 0051-0021-21 (Bottle of 60 capsules).5 mg dark brown capsules (Identified UM).NDC 0051-0022-21 (Bottle of 60 capsules).10 mg orange capsules (Identified UM).NDC 0051-0023-21 (Bottle of 60 capsules).Storage ConditionsMARINOL capsules should be packaged in a well-closed container and stored in a cool environment between 8° and 15°C (46° and 59°F) and alternatively could be stored in a refrigerator. Protect from freezing.